11 February 2026 – In the frame of the ICPerMed Strategic Working Group on Internationalisation, ICPerMed organised a webinar on 26 February 2026. Dr Frédérique Nowak, deputy coordinator, presented the 2025 French Genomic Medicine Initiative and its future perspective.
The 2025 French Genomic Medicine Initiative: Integrating genomic medicine into healthcare systems is a health policy challenge that requires continuously transferring scientific advances into clinics and ensuring equal access for patients. France was one of the first countries to integrate genome sequencing into clinical practice at a nationwide level, with the ambition to provide more accurate diagnostics and personalised treatments. Since 2016, the French government has invested €239M in the 2025 French Genomic Medicine Initiative (PFMG2025) which has so far focused on patients with rare diseases (RD), cancer genetic predisposition (CGP) and cancers. PFMG2025 has addressed numerous challenges to set up an operational organisational framework. As of December the 31st 2023, 12,737 results were returned to prescribers for RD/CGP patients (median delivery time: 202 days, diagnostic yield: 30.6%) and 3109 for cancer patients (median delivery time: 45 days). PFMG2025’s future priorities encompass ensuring economic sustainability, strengthening links with research, empowering patients and practitioners, and fostering collaborations with European partners.
Read more in the ICPerMed Best Practice Example: 2025 French Genomic Medicine Initiative.
Frédérique Nowak
After a master in bioengineering from the Ecole Centrale of Paris, Frédérique Nowak started her career at the Institut Gustave Roussy, where she got a PhD in Molecular Pharmacology in 1996. After her PhD, she joined Genset, a biotechnology company, where she has been project manager for innovative projects in high-throughput molecular cytogenetics. Between 2002 and 2006, she was responsible for a R&D team at the Serono Genetics Institute of the Serono pharmaceutical company in Evry, France. In 2006, she joined the Institut National du Cancer (INCa), the health and science agency in charge of cancer control in France, where she was the Head of the Biology, Technology Transfer and Innovations Department. She was more particularly in charge of the coordination of the INCa’s precision oncology programs. In 2019, she joined Inserm to be the deputy coordinator of the 2025 French Genomic Medicine Initiative, a national initiative for integrating genomic medicine in routine practice, before becoming its coordinator in 2021.
This is the fourth event of a series of webinars with the aim to overall increase the awareness about Personalised Medicine and to share information about activities and successes in the field.